These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 33076392)

  • 61. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient.
    Soufir N; Ribojad M; Magnaldo T; Thibaudeau O; Delestaing G; Daya-Grosjean L; Rivet J; Sarasin A; Basset-Seguin N
    J Invest Dermatol; 2002 Dec; 119(6):1355-60. PubMed ID: 12485439
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth.
    Williams RT; Barnhill LM; Kuo HH; Lin WD; Batova A; Yu AL; Diccianni MB
    PLoS One; 2014; 9(2):e88219. PubMed ID: 24505435
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
    Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alterations of p14
    López F; Sampedro T; Llorente JL; Hermsen M; Álvarez-Marcos C
    Pathol Oncol Res; 2017 Jan; 23(1):63-71. PubMed ID: 27377733
    [TBL] [Abstract][Full Text] [Related]  

  • 65. P16(INK4A) is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation.
    Chazal M; Marionnet C; Michel L; Mollier K; Dazard JE; Della Valle V; Larsen CJ; Gras MP; Basset-Séguin N
    Oncogene; 2002 Apr; 21(17):2652-61. PubMed ID: 11965538
    [TBL] [Abstract][Full Text] [Related]  

  • 66. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
    Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
    Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.
    Sharpless NE; Kannan K; Xu J; Bosenberg MW; Chin L
    Oncogene; 2003 Aug; 22(32):5055-9. PubMed ID: 12902988
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunohistochemical [corrected] detection of the alternate INK4a-encoded tumor suppressor protein p14(ARF) in archival human cancers and cell lines using commercial antibodies: correlation with p16(INK4a) expression.
    Geradts J; Wilentz RE; Roberts H
    Mod Pathol; 2001 Nov; 14(11):1162-8. PubMed ID: 11706079
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
    Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M
    Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
    Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K
    J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rapid asymmetric evolution of a dual-coding tumor suppressor INK4a/ARF locus contradicts its function.
    Szklarczyk R; Heringa J; Pond SK; Nekrutenko A
    Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12807-12. PubMed ID: 17652172
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma.
    Ghiorzo P; Gargiulo S; Pastorino L; Nasti S; Cusano R; Bruno W; Gliori S; Sertoli MR; Burroni A; Savarino V; Gensini F; Sestini R; Queirolo P; Goldstein AM; Scarrà GB
    Hum Mol Genet; 2006 Sep; 15(18):2682-9. PubMed ID: 16893909
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Deletion of RD
    Poi MJ; Knobloch TJ; Li J
    DNA Repair (Amst); 2017 Sep; 57():50-55. PubMed ID: 28688373
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
    Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
    Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.
    Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D
    Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A melanoma-predisposing germline CDKN2A mutation with functional significance for both p16 and p14ARF.
    Hashemi J; Lindström MS; Asker C; Platz A; Hansson J; Wiman KG
    Cancer Lett; 2002 Jun; 180(2):211-21. PubMed ID: 12175554
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition.
    Abdel-Rahman MH; Pilarski R; Massengill JB; Christopher BN; Noss R; Davidorf FH
    Melanoma Res; 2011 Jun; 21(3):175-9. PubMed ID: 21412176
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mutual exclusivity analysis of genetic and epigenetic drivers in melanoma identifies a link between p14 ARF and RARβ signaling.
    Dahl C; Christensen C; Jönsson G; Lorentzen A; Skjødt ML; Borg Å; Pawelec G; Guldberg P
    Mol Cancer Res; 2013 Oct; 11(10):1166-78. PubMed ID: 23851445
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression.
    Maruo S; Zhao B; Johannsen E; Kieff E; Zou J; Takada K
    Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1919-24. PubMed ID: 21245331
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma.
    Laud K; Marian C; Avril MF; Barrois M; Chompret A; Goldstein AM; Tucker MA; Clark PA; Peters G; Chaudru V; Demenais F; Spatz A; Smith MW; Lenoir GM; Bressac-de Paillerets B;
    J Med Genet; 2006 Jan; 43(1):39-47. PubMed ID: 15937071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.